why do pbms limit glp-1 medications How Employers Can Manage Costs in Their Health Plans why do pbms limit glp-1
Description
There's plenty of research happening around the world

In the context of implementing patient-centric holistic cardio-metabolic risk management as a priority, the choice of various combinations of antidiabetic agents should be individualized

Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below:

In India, many people will use it without any of that

Not all GLP-1 products are FDA-approved
Discover best practices for incorporating exercise alongside GLP-1 medications.
